ROSSI, OLIVIERO
 Distribuzione geografica
Continente #
NA - Nord America 1.097
AS - Asia 1.013
EU - Europa 907
SA - Sud America 119
AF - Africa 20
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.169
Nazione #
US - Stati Uniti d'America 1.068
RU - Federazione Russa 358
CN - Cina 327
SG - Singapore 273
IT - Italia 226
HK - Hong Kong 101
BR - Brasile 92
KR - Corea 88
VN - Vietnam 87
PL - Polonia 59
FR - Francia 46
IE - Irlanda 39
IN - India 33
DE - Germania 32
GB - Regno Unito 27
JP - Giappone 26
NL - Olanda 24
FI - Finlandia 23
SE - Svezia 23
ID - Indonesia 18
CA - Canada 13
CH - Svizzera 13
ES - Italia 13
AU - Australia 12
JO - Giordania 11
IL - Israele 10
AR - Argentina 7
MX - Messico 7
AE - Emirati Arabi Uniti 5
CO - Colombia 5
EC - Ecuador 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
JM - Giamaica 4
LT - Lituania 4
NG - Nigeria 4
TH - Thailandia 4
UA - Ucraina 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
BJ - Benin 3
EG - Egitto 3
MA - Marocco 3
PY - Paraguay 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HU - Ungheria 2
IQ - Iraq 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
UY - Uruguay 2
AL - Albania 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.169
Città #
Santa Clara 234
Ashburn 208
Singapore 190
Hefei 104
Seoul 88
Hong Kong 85
San Jose 78
Warsaw 58
Fairfield 46
Beijing 41
Milan 41
Dublin 39
Moscow 30
Florence 29
Ho Chi Minh City 28
Cambridge 23
Chandler 23
Wilmington 22
Hanoi 21
Buffalo 20
Seattle 20
Shanghai 19
The Dalles 19
Dallas 18
Houston 18
Lauterbourg 18
Woodbridge 18
Los Angeles 17
Altamura 14
Council Bluffs 14
Lawrence 14
Rome 14
Frankfurt am Main 13
Kent 13
Munich 13
New York 13
Zurich 13
Helsinki 12
Luni 12
Mumbai 11
São Paulo 11
Jakarta 10
Melbourne 9
Orem 9
Osaka 9
Paris 9
Tel Aviv 9
Guangzhou 8
London 8
Madrid 8
Tokyo 8
Ann Arbor 7
Chennai 7
Lappeenranta 7
Princeton 7
Bengaluru 6
Chicago 6
San Diego 6
Boston 5
Haiphong 5
Livorno 5
Xi'an 5
Abuja 4
Alba 4
Amman 4
Amsterdam 4
Johannesburg 4
Tashkent 4
Turku 4
Baku 3
Bogotá 3
Brooklyn 3
Bắc Ninh 3
Campi Bisenzio 3
Clifton 3
Cotonou 3
Hải Dương 3
Jeddah 3
Montreal 3
Ninh Bình 3
Phoenix 3
Roubaix 3
Toronto 3
Washington 3
Aioichō 2
Bekasi 2
Bexley 2
Biên Hòa 2
Boardman 2
Budapest 2
Bắc Giang 2
Camaiore 2
Chaozhou 2
Colle di Val d'Elsa 2
Da Nang 2
Denver 2
Dong Ket 2
Dubai 2
Formosa 2
Genoa 2
Totale 1.980
Nome #
Mepolizumab Reduces Inflammatory Eosinophils in Nasal Polyp Tissue and Restores Histological Alterations 285
Concomitant Bilastine and Montelukast as Additive Therapy for Seasonal Allergic Rhinoconjunctivits and Mild-to-Moderate Asthma. The SKY Study 235
High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients 218
The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatment 177
Migrants and allergy: a new view of the atopic march 170
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19 165
Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study 164
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 164
EGPA Phenotyping: Not Only ANCA, but Also Eosinophils 160
Low-dose mepolizumab effectiveness in patients suffering from eosinophilic granulomatosis with polyangiitis 158
Primary antibody deficiencies represent an underestimated comorbidity in asthma patients: efficacy of immunoglobulin replacement therapy in asthma control 153
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study 149
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 148
Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience 145
Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience 143
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 125
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 124
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 116
Management of patients with severe asthma: results from a survey among allergists and clinical immunologists of the Central Italy Inter-Regional Section of SIAAIC 101
Asthma phenotype can be influenced by recurrent respiratory infections in patients with primary antibody deficiency: the impact of Ig therapy 95
Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes 4
Totale 3.199
Categoria #
all - tutte 9.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 10 7
2021/202245 0 0 0 2 0 11 0 1 6 4 8 13
2022/2023175 12 37 13 6 5 27 25 12 17 4 7 10
2023/2024195 2 12 20 18 28 17 10 38 4 20 9 17
2024/2025977 28 90 55 144 226 98 46 57 60 29 51 93
2025/20261.562 238 211 234 200 147 45 185 64 76 100 62 0
Totale 3.199